Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in PRLD — Prelude Therapeutics Inc

CIK 1595888 NEW YORK, NY
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$659,933 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
13 quarters on record

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Derivatives in PRLD

reported options exposure · as of Jun 30, 2026
CallValue
$341,653
CallShares
64,100
PutValue
$107,133
PutShares
20,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in PRLD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341,653 64,100
2026-06-30 $107,133 20,100
2026-03-31 $659,933 192,963
2025-12-31 $322,016 111,040
2025-09-30 $50,143 34,822
2025-06-30 $74,227 91,753
2024-09-30 $21,447 10,361
2024-06-30 $49,331 12,948
2024-03-31 $77,679 16,388
2023-12-31 $140,811 32,977
2023-03-31 $367,479 64,470
2022-12-31 $101,514 16,807
2021-12-31 $127,500 10,241
2020-09-30 $222,208 7,375